CytomX Therapeutics Inc (NASDAQ:CTMX)

5.07
Delayed Data
As of Oct 20
 +0.03 / +0.60%
Today’s Change
4.28
Today|||52-Week Range
10.05
-22.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues7.7M15.0M71.6M59.5M
 
 
 
 
 
Depreciation And Amortization1.2M1.7M1.6M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.7M72.9M116.2M135.5M
 
 
 
 
 
Research And Development28.4M54.8M92.3M103.9M
 
 
 
 
 
Total Operating Expenses40.9M74.6M117.9M137.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.2M-59.6M-46.3M-77.9M
 
 
 
 
 
Extraordinary Charge-1.7M0.000.000.00
 
 
Interest Expense On Debt1.7M1.7M0.000.00
 
 
 
Other Expenses-28.0K-69.0K-27.0K-68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.4M-58.9M-43.6M-70.3M
 
 
 
 
 
Income Taxes-10.0K-19.0K-513.0K-14.3M
 
 
 
 
 
Preferred Dividend-6.7M0.000.000.00
 
 
Net Income-35.4M-58.9M-43.1M-84.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.6M36.2M37.2M41.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.6M36.2M37.2M41.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.90-$1.63-$1.16-$2.03
 
 
 
 
 
EPS Diluted-$4.90-$1.63-$1.16-$2.03